Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirokazu Ogino

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Medical Investigation : JMI|May 12, 2024
Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectivesMasaki Hanibuchi, Hirokazu Ogino, Seidai Sato, et al.
International Journal of Clinical Oncology|April 20, 2006
Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancerSeiji Yano, Yuka Matsumori, Kenji Ikuta, et al.
Molecular and Clinical Oncology|April 11, 2019
Paclitaxel for relapsed small-cell lung cancer patients with idiopathic interstitial pneumoniasAtsuro Saijo, Masaki Hanibuchi, Hirokazu Ogino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient miceQi Li, Seiji Yano, Hirokazu Ogino, et al.
Acute Medicine & Surgery|November 11, 2017
Analysis of the clinical backgrounds of patients who developed respiratory acidosis under high-flow oxygen therapy during emergency transportHirokazu Ogino, Naoki Nishimura, Yasuhiko Yamano, et al.
BMC Pulmonary Medicine|November 16, 2021
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesotheliomaHiroto Yoneda, Hiroshi Nokihara, Atsushi Mitsuhashi, et al.
Thoracic Cancer|September 15, 2022
Efficacy and safety of second-line chemotherapy for patients with advanced non-small cell lung cancer complicated by interstitial lung diseaseKenji Otsuka, Hiroshi Nokihara, Atsushi Mitsuhashi, et al.
Thoracic Cancer|January 22, 2022
Radiation therapy induces an abscopal effect and upregulates programmed death-ligand 1 expression in a patient with non-small cell lung cancerYutaka Morita, Atsuro Saijo, Hiroshi Nokihara, et al.
BMC Cancer|June 1, 2022
Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusionHiroshi Nokihara, Hirokazu Ogino, Atsushi Mitsuhashi, et al.
Molecular Cancer Therapeutics|January 14, 2009
Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient miceTadaaki Yamada, Hiroaki Muguruma, Seiji Yano, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Medical Investigation : JMI|May 12, 2024
Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectivesMasaki Hanibuchi, Hirokazu Ogino, Seidai Sato, et al.
International Journal of Clinical Oncology|April 20, 2006
Current status and perspective of angiogenesis and antivascular therapeutic strategy: non-small cell lung cancerSeiji Yano, Yuka Matsumori, Kenji Ikuta, et al.
Molecular and Clinical Oncology|April 11, 2019
Paclitaxel for relapsed small-cell lung cancer patients with idiopathic interstitial pneumoniasAtsuro Saijo, Masaki Hanibuchi, Hirokazu Ogino, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2007
The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient miceQi Li, Seiji Yano, Hirokazu Ogino, et al.
Acute Medicine & Surgery|November 11, 2017
Analysis of the clinical backgrounds of patients who developed respiratory acidosis under high-flow oxygen therapy during emergency transportHirokazu Ogino, Naoki Nishimura, Yasuhiko Yamano, et al.
BMC Pulmonary Medicine|November 16, 2021
Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesotheliomaHiroto Yoneda, Hiroshi Nokihara, Atsushi Mitsuhashi, et al.
Thoracic Cancer|September 15, 2022
Efficacy and safety of second-line chemotherapy for patients with advanced non-small cell lung cancer complicated by interstitial lung diseaseKenji Otsuka, Hiroshi Nokihara, Atsushi Mitsuhashi, et al.
Thoracic Cancer|January 22, 2022
Radiation therapy induces an abscopal effect and upregulates programmed death-ligand 1 expression in a patient with non-small cell lung cancerYutaka Morita, Atsuro Saijo, Hiroshi Nokihara, et al.
BMC Cancer|June 1, 2022
Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusionHiroshi Nokihara, Hirokazu Ogino, Atsushi Mitsuhashi, et al.
Molecular Cancer Therapeutics|January 14, 2009
Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient miceTadaaki Yamada, Hiroaki Muguruma, Seiji Yano, et al.
Pageof 7